Benzodiazepine antibody
Ref. 3D-10-1369
| 1mg | 217.00 € |
Product Information
The Benzodiazepine antibody is a monoclonal antibody that has been developed for its neutralizing properties against hepatocyte growth factor (HGF). This antibody has been immobilized using chromatographic techniques, making it highly effective in targeting and neutralizing HGF. It binds to the protein collagen and angptl3, which are key binding proteins involved in the activation of HGF. The Benzodiazepine antibody has shown cytotoxic effects on cells that overexpress HGF receptors, making it a promising therapeutic option for conditions associated with abnormal HGF signaling. Additionally, this antibody has also demonstrated inhibitory effects on epidermal growth factor (EGF), further expanding its potential applications in various disease settings. With its targeted action and potent neutralizing capabilities, the Benzodiazepine antibody offers a promising avenue for therapeutic intervention in conditions characterized by dysregulated HGF signaling.
Chemical properties
Technical inquiry about: 3D-10-1369 Benzodiazepine antibody
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
